Defective Medical Devices
Defective medical devices can cause injury and harm to unknowing patients. Medical device users expect treatments to work effectively and safely without undue risk or harm. Independent institutions, such as the Food and Drug Administration (FDA), place medical devices through extensive testing before releasing them to the consumer market. If potential risks and side effects are found, they are documented thoroughly and the user of the medical device is informed of any potential detriment to their health.
Regardless of this testing, medical devices are sometimes found to be faulty under certain circumstances or to raise the overall chance of illness or injury. The Guidant Defibrillator is one example of a defective medical device. Once installed, some models of the defibrillator run the risk of causing serious injury to the patient at an unknown time. Dealing with the risks associated with a defective medical device can have life-altering consequences.
In the event a defective medical device causes injury or death, the manufacturers of the device may be held legally liable for marketing a dangerous product. Some legal actions associated with defective medical devices evolve into class action or mass tort suits, whereby those affected by the hazardous devices can make a personal injury claim for a predetermined amount of compensation.
If you or a loved one has suffered an injury, illness, or death due to a defective medical device, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Defective Medical Devices
Links on the Web
 MedWatch Safety Alert RSS FeedFDA MedWatch Safety Alerts |
| Thu, 17 May 2012 14:45:00 -0400 Zithromax (azithromycin): FDA Statement on risk of cardiovascular death A retrospective cohort study reports small increase in risk of cardiovascular deaths and risk of all cause deaths associated with 5 day course of antibiotic drug Click here to read this Defective Medical Devices news article. |
| Mon, 14 May 2012 13:30:00 -0400 Gilenya (fingolimod): Drug Safety Communication - Safety Review of a Reported Death After the First Dose UPDATED 05/14/2012. New recommendations for monitoring patients, and new contraindications, and dosing & administration information for use in certain patients. Click here to read this Defective Medical Devices news article. |
| Mon, 14 May 2012 13:05:00 -0400 Hydromorphone Hydrochloride Injection 1 MG/ML, (C-II) 1 ML Fill In 2.5 ML Carpuject: Recall - May Contain More Than the Intended Fill Volume An overdose of Hydromorphone may result in life-threatening consequences, including respiratory depression (slowed breathing or suspension of breathing), low blood pressure, and reduced heart rate including circulatory collapse. Click here to read this Defective Medical Devices news article. |
| Mon, 07 May 2012 13:20:00 -0400 Revlimid (lenalidomide): Ongoing Safety Review - Increased Risk of Developing New Malignancies UPDATED 05/07/2012. Increased risk of developing acute myelogenous leukemia, myelodysplastic syndromes, and Hodgkin lymphoma in patients being treated with Revlimid. Click here to read this Defective Medical Devices news article. |
| Fri, 04 May 2012 11:00:00 -0400 Certain Compounded Drugs from Franck's: FDA Issues Second Warning to Physicians [UPDATED 05/04/2012] The Centers for Disease Control and Prevention (CDC) has advised healthcare personnel to avoid use of compounded products labeled as sterile from Franck?s during the ongoing investigation. Click here to read this Defective Medical Devices news article. |
| Thu, 26 Apr 2012 14:45:00 -0400 Victrelis (boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs: Drug Safety Communication - Drug Interactions UPDATED 04/26/2012. Label revised to state that co-administration of Victrelis with certain ritonavir-boosted human immunodeficiency virus protease inhibitors is not recommended. Originally posted 02/09/2012 Click here to read this Defective Medical Devices news article. |
| National Institutes of Health (NIH) News Releases News Releases from the National Institutes of Health (NIH) |
| Fri, 18 May 2012 12:10 EDT Optogenetics project takes top NIDA Addiction Science Award A project that maps dopamine circuits in the prefrontal cortex through optogenetic manipulation was given top honors in this year?s annual Addiction Science Awards at the 2012 Intel International Science and Engineering Fair (ISEF) -- the world's largest science competition for high school students. The awards were presented by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and Friends of NIDA, a coalition that supports NIDA?s mission. The Intel ISEF Addiction Science Awards were presented at a ceremony Thursday night at the David L. Lawrence Convention Center in Pittsburgh. Click here to read this Defective Medical Devices news article. |
| Thu, 17 May 2012 11:00 EDT NIH-led study finds genetic test results do not trigger increased use of health services People have increasing opportunities to participate in genetic testing that can indicate their range of risk for developing a disease. Receiving these results does not appreciably drive up or diminish test recipients? demand for potentially costly follow-up health services, according to a study performed by researchers at the National Institutes of Health and colleagues at other institutions. Click here to read this Defective Medical Devices news article. |
| Thu, 17 May 2012 08:20 EDT NIH study finds that coffee drinkers have lower risk of death Older adults who drank coffee -- caffeinated or decaffeinated -- had a lower risk of death overall than others who did not drink coffee, according a study by researchers from the National Cancer Institute (NCI), part of the National Institutes of Health, and AARP. Click here to read this Defective Medical Devices news article. |
| Wed, 16 May 2012 13:46 EDT Paralyzed individuals use thought-controlled robotic arm to reach and grasp In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own -- for the first time in nearly 15 years -- by using her thoughts to direct a robotic arm. The trial, funded in part by the National Institutes of Health, is evaluating the safety and feasibility of an investigational device called the BrainGate neural interface system. Click here to read this Defective Medical Devices news article. |
| Wed, 16 May 2012 13:41 EDT NIH-funded research provides new clues on how ApoE4 affects Alzheimer's risk Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of ApoE damages the blood vessels that feed the brain. Click here to read this Defective Medical Devices news article. |
| Tue, 15 May 2012 08:40 EDT NINR welcomes five new members to the National Advisory Council for Nursing Research The National Institute of Nursing Research (NINR) announces five new members to the National Advisory Council for Nursing Research (NACNR), the institute's principal advisory board. Members of the council are drawn from the scientific and lay communities, embodying a diverse perspective from the fields of nursing, public and health policy, law, and economics. NINR, a component of the National Institutes of Health, is the primary federal agency for the support of nursing research. Click here to read this Defective Medical Devices news article. |
